In our first podcast interview of 2023, BioPharma Reporter spoke with Dr Sarah Bateup, therapy lead at Clerkenwell Health, about the potential of psychedelic medicine and her work within the psychedelic therapy training space.

test

Oct 16th, 2023 28m 33s

What kind of consistency can industry expect from the FDA post pandemic?

Jul 22nd, 2021 15m 5s

How the US Food and Drug Administration (FDA) exercises flexibility has been an important and emerging issue for the past several years.

What kind of consistency can industry expect from the FDA post pandemic?

Jul 22nd, 2021 15m 5s

How the US Food and Drug Administration (FDA) exercises flexibility has been an important and emerging issue for the past several years.

Chicago emerging as a life science and biopharma hub

May 17th, 2021 14m 56s

Many turn to Boston and North Carolina’s Research Triangle to set up life science companies, but Chicago is now also fast becoming a draw in this respect. The city is emerging as a life science and biopharma hub and seems poised for even furthe

Chicago emerging as a life science and biopharma hub

May 17th, 2021 14m 56s

Will Biden backed bills boost biosimilars uptake in the US?

May 7th, 2021 8m 48s

Today we are launching a new series called The BioPharma Pod. Kicking off these broadcasts is the hot topic of biosimilars.

Continuous bioprocessing: A ‘life changing’ method, says NIBRT

Mar 30th, 2018 2m 39s

Additive value: Inside GE Healthcare’s 3D printing and design lab

Nov 21st, 2017 2m 6s

PETA protests against Charles River at Biotech Week Boston

Sep 27th, 2017 1m 34s

Bioproduction bottlenecks increasing due to staff shortages, says report

Aug 15th, 2017 4m 1s

A shortage in expertise is causing bottlenecks in the biomanufacturing space with around half of drugmakers struggling to fill processing positions, an industry report finds.

Bioproduction bottlenecks increasing due to staff shortages, says report

Aug 15th, 2017 4m 1s

A shortage in expertise is causing bottlenecks in the biomanufacturing space with around half of drugmakers struggling to fill processing positions, an industry report finds.

Continuous chromatography and single-use filtration at BPI Europe

May 2nd, 2017 2m 47s

Getting a feel for biomanufacturing at the Biotech Training Facility

Apr 24th, 2017 2m 20s

Pall: Bioprocessing's future is made of virtual reality

Apr 26th, 2016 1m 33s

BioFinance Vision: Are Pfizer and Novartis in the biosimilar saddle?

Jul 23rd, 2015 2m 23s

Bio-Finance Vision... Baxalta, Pall and more in glorious technicolour

Jul 9th, 2015 2m 5s

Virtual Sterility? GE uses Xbox tech to showcase products

Apr 14th, 2015 2m

Happy Holidays 2014 from William Reed Business Media!

Dec 18th, 2014 2m 58s

The holidays are fast upon us, so let’s put ‘business’ to one side and get into the festive mood. To keep in the spirit of things, we’ve got a ‘gift’ for you – enjoy. Happy Holidays!

Consolidation prevalent in industry, says third largest CMO

Mar 26th, 2014 6m 23s

Aenova says the acquisition of Haupt Pharma and Patheon’s merger with DSM are evidence of consolidation in the CMO industry, as it looks to further increase its global footprint.

Catalent commits to ADCs by upping its stake in Redwood

Mar 25th, 2014 4m 36s

Catalent has increased its stake in Redwood Biosciences telling us it is committed to the development of antibody-drug conjugates (ADCs) and the SMARTag technology platform.

So far, so very good: Pall and ATMI talk integration at interphex

Mar 21st, 2014 4m 48s

While there will always be space for stainless steel systems, single-use technology is now mainstream according to Pall and ATMI.

Patheon and DSM crossover limited, more growth targeted says DPx

Mar 20th, 2014 4m 1s

Patheon and DSM’s Pharma Products merger is “highly complementary” with crossover limited to North American oral solid manufacturing growth, says DPx as it targets further growth opportunities.